Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.60 |
| ▸ | MMP3 | P08254 | 12/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6586078 | 0.92 | MMP2 (0.64) | MMP2MMP3L3MBTL1ALDH1A1PKM | |
| SCHEMBL6586997 | 0.91 | MMP2 (0.59) | MMP2MMP3L3MBTL1EPHX1PKM | |
| SCHEMBL6584009 | 0.91 | MMP2 (0.64) | MMP2MMP3L3MBTL1MMP14 | |
| SCHEMBL6584555 | 0.90 | MMP2 (0.63) | MMP2MMP3L3MBTL1EPHX1POLB | |
| SCHEMBL6584396 | 0.89 | MMP2 (0.54) | MMP2MMP3EPHX1ALDH1A1 | |
| SCHEMBL6584500 | 0.88 | MMP2 (0.53) | MMP2MMP3L3MBTL1ALDH1A1PKM | |
| SCHEMBL6588431 | 0.88 | MMP2 (0.66) | MMP2MMP3L3MBTL1 | |
| SCHEMBL6965353 | 0.87 | MMP2 (0.46) | MMP2MMP3L3MBTL1ALDH1A1PKM | |
| SCHEMBL6584742 | 0.83 | MMP2 (0.68) | MMP2MMP3L3MBTL1ALDH1A1PKM | |
| SCHEMBL6590191 | 0.83 | MMP2 (0.63) | MMP2MMP3L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |